ProteoTech, Inc.

New At The Helm Company Changes ASHBURN , Theodore T., MD, PhD To: Dicerna Pharmaceuticals Inc. , SVP, Product Strategy & Ops. (December) From: Genzyme/Sanofi Oncology, Global Product Leader, Le

In Vitro Diagnostics Acquisitions

Like oncology 15 years ago, the neurodegenerative space has high unmet needs and great potential, but also risk. Scientific advances and a few successful drugs are attracting interest but before makin

Neurodegenerative disorders represent a tremendous unmet medical need. Millions of people are affected by such diseases as Alzheimer's, Huntington's Parkinson's, MS and ALS, not to mention those suffe